Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger Stupp

Showing results (41-50 of 314) with videos related to

Pageof 32
Sort By:
Cancer Journal (Sudbury, Mass.)|February 1, 2012
Individualized targeted therapy for glioblastoma: fact or fiction?Michael Weller, Roger Stupp, Monika Hegi, et al.
Current Opinion in Neurology|October 25, 2013
Malignant astrocytoma in elderly patients: where do we stand?Ghazaleh Tabatabai, Roger Stupp, Wolfgang Wick, et al.
Nature Medicine|July 9, 2009
Will integrin inhibitors have proangiogenic effects in the clinic?Michael Weller, David Reardon, Burt Nabors, et al.
Current Neurology and Neuroscience Reports|March 20, 2012
Clinical implications of molecular neuropathology and biomarkers for malignant gliomaGhazaleh Tabatabai, Monika Hegi, Roger Stupp, et al.
Neurosurgery Clinics of North America|November 23, 2020
Role of Resection in Glioblastoma ManagementMark W Youngblood, Roger Stupp, Adam M Sonabend
Lancet (London, England)|February 21, 2019
Improving survival in molecularly selected glioblastomaRoger Stupp, Rimas V Lukas, Monika E Hegi
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|March 9, 2004
Combined modality treatment with full-dose chemotherapy and concomitant boost radiotherapy for advanced head and neck carcinomaJürg Kutter, Mahmut Ozsahin, Philippe Monnier, et al.
Journal of Neuro-Oncology|October 9, 2017
Hospital volume and group expertise in newly diagnosed glioblastoma managementRimas V Lukas, Maciej S Lesniak, Roger Stupp
Cell Death & Disease|April 21, 2017
Biological activity of tumor-treating fields in preclinical glioma modelsManuela Silginer, Michael Weller, Roger Stupp, et al.
Current Treatment Options in Neurology|December 18, 2013
Treatment of primary CNS lymphomaPatrick Roth, Roger Stupp, Günter Eisele, et al.
Pageof 32

Showing results (41-50 of 314) with videos related to

Sort By:
Pageof 32
Cancer Journal (Sudbury, Mass.)|February 1, 2012
Individualized targeted therapy for glioblastoma: fact or fiction?Michael Weller, Roger Stupp, Monika Hegi, et al.
Current Opinion in Neurology|October 25, 2013
Malignant astrocytoma in elderly patients: where do we stand?Ghazaleh Tabatabai, Roger Stupp, Wolfgang Wick, et al.
Nature Medicine|July 9, 2009
Will integrin inhibitors have proangiogenic effects in the clinic?Michael Weller, David Reardon, Burt Nabors, et al.
Current Neurology and Neuroscience Reports|March 20, 2012
Clinical implications of molecular neuropathology and biomarkers for malignant gliomaGhazaleh Tabatabai, Monika Hegi, Roger Stupp, et al.
Neurosurgery Clinics of North America|November 23, 2020
Role of Resection in Glioblastoma ManagementMark W Youngblood, Roger Stupp, Adam M Sonabend
Lancet (London, England)|February 21, 2019
Improving survival in molecularly selected glioblastomaRoger Stupp, Rimas V Lukas, Monika E Hegi
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|March 9, 2004
Combined modality treatment with full-dose chemotherapy and concomitant boost radiotherapy for advanced head and neck carcinomaJürg Kutter, Mahmut Ozsahin, Philippe Monnier, et al.
Journal of Neuro-Oncology|October 9, 2017
Hospital volume and group expertise in newly diagnosed glioblastoma managementRimas V Lukas, Maciej S Lesniak, Roger Stupp
Cell Death & Disease|April 21, 2017
Biological activity of tumor-treating fields in preclinical glioma modelsManuela Silginer, Michael Weller, Roger Stupp, et al.
Current Treatment Options in Neurology|December 18, 2013
Treatment of primary CNS lymphomaPatrick Roth, Roger Stupp, Günter Eisele, et al.
Pageof 32